These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2083333)

  • 1. [Kemantane pharmacokinetics in rats].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Janku I; Buchar E
    Biull Eksp Biol Med; 1990 Nov; 110(11):501-3. PubMed ID: 2083333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical pharmacokinetics of kemantane].
    Boĭko SS; Zherdev VP; Kisliak NA
    Farmakol Toksikol; 1991; 54(1):57-9. PubMed ID: 1860503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interspecific differences in kemantan pharmacokinetics].
    Boĭko SS; Zherdev VP; Kisliak NA; Piatin BM; Klimova NV; Glan PV; Dvorianinov AA
    Eksp Klin Farmakol; 1994; 57(6):48-50. PubMed ID: 7756963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic study of 2-(N-benzylamino)adamatane (bemantan) by a gas-liquid chromatographic method].
    Liubimov BI; Skoldinov AP; Boĭko SS; Rodionov AP; Mozhaeva TIa
    Farmakol Toksikol; 1980; 43(4):408-11. PubMed ID: 7439377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
    Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M
    Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
    Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
    Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics and metabolism of heptapeptide--a prospective synthetic analog of tuftsin with psychostimulating action in rats].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Seredenin SB; Alfeeva LIu; Andreeva LA; Bezmenova SV; Miasoedov NF
    Eksp Klin Farmakol; 1998; 61(5):42-5. PubMed ID: 9854633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disposition of 14C-muroctasin in laboratory animals.
    Ono K; Masayasu H; Hashimoto F; Yamada M; Takegoshi T
    Arzneimittelforschung; 1988 Jul; 38(7A):1009-14. PubMed ID: 3190792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bemetil pharmacokinetics in an experiment on rats].
    Boĭko SS; Bobkov IuG; Zherdev VP; Dvorianinov AA
    Farmakol Toksikol; 1987; 50(5):54-6. PubMed ID: 3691781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetics of 3H-remantadine accumulation and excretion in the tissues of pregnant mice and their fetuses].
    Pravdina NF; Shobukhov VM; Petrova IG; Tul'kes SG; Galegov GA
    Biull Eksp Biol Med; 1985 Jan; 99(1):74-6. PubMed ID: 3967076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, kinetics, antibody-bound and free serum determination of a 14C-labeled Escherichia coli extract after single oral administration in rats.
    van Dijk A; Bauer J; Sedelmeier EA; Bessler WG
    Arzneimittelforschung; 1997 Mar; 47(3):329-34. PubMed ID: 9105555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats.
    Wong YN; Quon CY; Holm KA; Burcham DL; Frey NL; Huang SM; Lam GN
    Drug Metab Dispos; 1996 Feb; 24(2):172-9. PubMed ID: 8742228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the distribution of 3[H]-himantane in the brain structures and the thymus of rats].
    Kovalev GI; Rodionov AP; Petrenko ES; Zolotarev IuA
    Eksp Klin Farmakol; 2003; 66(3):50-2. PubMed ID: 12924235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat. II. Pharmacokinetics and stereoselectivity of metabolism and excretion in vivo and in the perfused liver.
    te Koppele JM; Dogterom P; Vermeulen NP; Meijer DK; van der Gen A; Mulder GJ
    J Pharmacol Exp Ther; 1986 Dec; 239(3):905-14. PubMed ID: 3795049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of amoxapine and its active metabolites.
    Calvo B; García MJ; Pedraz JL; Mariño EL; Domínguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):180-5. PubMed ID: 3997304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and pharmacokinetics of a new antifolate, 2,4-diamino-5-adamantyl-6-methylpyrimidine, in dogs.
    Zakrzewski SF; Pavelic Z; Greco WR; Bullard G; Creaven PJ; Mihich E
    Cancer Res; 1982 Jun; 42(6):2177-83. PubMed ID: 7074598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.